Invasive Bacterial Infections in Subjects with Genetic and Acquired Susceptibility and Impacts on Recommendations for Vaccination: A Narrative Review
- PMID: 33668334
- PMCID: PMC7996259
- DOI: 10.3390/microorganisms9030467
Invasive Bacterial Infections in Subjects with Genetic and Acquired Susceptibility and Impacts on Recommendations for Vaccination: A Narrative Review
Abstract
The WHO recently endorsed an ambitious plan, "Defeating Meningitis by 2030", that aims to control/eradicate invasive bacterial infection epidemics by 2030. Vaccination is one of the pillars of this road map, with the goal to reduce the number of cases and deaths due to Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae and Streptococcus agalactiae. The risk of developing invasive bacterial infections (IBI) due to these bacterial species includes genetic and acquired factors that favor repeated and/or severe invasive infections. We searched the PubMed database to identify host risk factors that increase the susceptibility to these bacterial species. Here, we describe a number of inherited and acquired risk factors associated with increased susceptibility to invasive bacterial infections. The burden of these factors is expected to increase due to the anticipated decrease in cases in the general population upon the implementation of vaccination strategies. Therefore, detection and exploration of these patients are important as vaccination may differ among subjects with these risk factors and specific strategies for vaccination are required. The aim of this narrative review is to provide information about these factors as well as their impact on vaccination against the four bacterial species. Awareness of risk factors for IBI may facilitate early recognition and treatment of the disease. Preventive measures including vaccination, when available, in individuals with increased risk for IBI may prevent and reduce the number of cases.
Keywords: Haemophilus influenzae; Neisseria meningitidis; Streptococcus agalactiae; Streptococcus pneumoniae; complement; genetic factors; group B streptococci; invasive bacterial infections; susceptibility.
Conflict of interest statement
M-K.T reports grants from GSK, grants from Pfizer, grants from Sanofi, outside the submitted work, M.-K.T. and A.-E.D. have a patent 630133 issued.
Similar articles
-
Invasive bacterial diseases: national surveillance in Italy and vaccination coverage in the Local Health Agency 4 "Chiavarese", Liguria region (Italy).J Prev Med Hyg. 2012 Jun;53(2):120-4. J Prev Med Hyg. 2012. PMID: 23240174
-
Risk factors for community-acquired bacterial meningitis.Infect Dis (Lond). 2017 Jun;49(6):433-444. doi: 10.1080/23744235.2017.1285046. Infect Dis (Lond). 2017. PMID: 28301990 Review.
-
Pediatric bacterial meningitis in Japan, 2013-2015 - 3-5 years after the wide use of Haemophilus influenzae type b and Streptococcus pneumoniae conjugated vaccines.J Infect Chemother. 2017 Jul;23(7):427-438. doi: 10.1016/j.jiac.2017.02.014. Epub 2017 Apr 26. J Infect Chemother. 2017. PMID: 28456490
-
The changing epidemiology of bacterial meningitis and invasive non-meningitic bacterial disease in scotland during the period 1983-99.Scand J Infect Dis. 2002;34(4):289-98. doi: 10.1080/00365540110080403. Scand J Infect Dis. 2002. PMID: 12064693
-
Community-acquired bacterial meningitis.Nat Rev Dis Primers. 2016 Nov 3;2:16074. doi: 10.1038/nrdp.2016.74. Nat Rev Dis Primers. 2016. PMID: 27808261 Review.
Cited by
-
Editorial for the Special Issue: Bacterial Meningitis-Epidemiology and Vaccination.Microorganisms. 2021 Apr 24;9(5):917. doi: 10.3390/microorganisms9050917. Microorganisms. 2021. PMID: 33923323 Free PMC article.
-
Product review on the IMD serogroup B vaccine Bexsero®.Hum Vaccin Immunother. 2022 Dec 31;18(1):2020043. doi: 10.1080/21645515.2021.2020043. Epub 2022 Feb 22. Hum Vaccin Immunother. 2022. PMID: 35192786 Free PMC article.
-
Biochemical implications of robotic surgery: a new frontier in the operating room.J Robot Surg. 2024 Feb 24;18(1):91. doi: 10.1007/s11701-024-01861-6. J Robot Surg. 2024. PMID: 38401027 Review.
References
-
- World Health Organization (WHO) Defeating meningitis by 2030; Proceedings of the First Meeting of the Technical Taskforce; World Health Organization, Geneva, Switzerland. 18–19 July 2018; WHO: 2019.
-
- Pinto M., Gonzalez-Diaz A., Machado M.P., Duarte S., Vieira L., Carrico J.A., Marti S., Bajanca-Lavado M.P., Gomes J.P. Insights into the population structure and pan-genome of Haemophilus influenzae. Infect. Genet. Evol. J. Mol. Epidemiol. Evol. Genet. Infect. Dis. 2019;67:126–135. doi: 10.1016/j.meegid.2018.10.025. - DOI - PubMed
-
- Dore N., Bennett D., Kaliszer M., Cafferkey M., Smyth C.J. Molecular epidemiology of group B streptococci in Ireland: Associations between serotype, invasive status and presence of genes encoding putative virulence factors. Epidemiol. Infect. 2003;131:823–833. doi: 10.1017/S0950268803008847. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources